To include your compound in the COVID-19 Resource Center, submit it here.

Varian Medical Systems, Cancer Research UK, The University of Auckland deal

The university granted Varian's Centella Therapeutics Inc. subsidiary exclusive, worldwide rights to CEN-209. Centella then

Read the full 151 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE